BusinessAdmin•Yahoo Finance RSS•11 hours ago
Trump's Support for Psychedelics Boosts Compass Pathways Stock: Is It Time to Invest?
Trump's backing of psychedelics has led to a rise in Compass Pathways stock, prompting investors to evaluate potential buying opportunities.
- • Former President Donald Trump's endorsement of psychedelics has significantly increased the stock price of Compass Pathways (CMPS).
- • Investors are now considering whether this surge presents a viable buying opportunity for CMPS shares.
- • The growing interest in psychedelics for mental health treatments is attracting attention from both investors and the medical community.
Source: Yahoo Finance RSS
Read original →
